Dr. Leonardo de Castro presented the 2011 edition of the National Ethical Guidelines for Health Research during the 30th anniversary celebration of the PCHRD-DOST.

Responding to the changing landscape of national health research system, the Philippine Health Research Ethics Board (PHREB) led by its Chair, Dr. Leonardo de Castro launched the 2011 edition of the National Ethical Guidelines for Health Research during the 30th anniversary of the Philippine Council for Health Research and Development of the Department of Science and Technology (PCHRD-DOST) at the Shangri-La Hotel, Makati City last March 16, 2012.

The National Ethical Guidelines for Health Research 2011 is the updated version of the 2006 guidelines. Guidelines for carrying out researches on clinical trials, herbal medicine, complementary

Colorectal cancer is one form of cancer which develops slowly over a period of many years. It is a cancer from uncontrolled cell growth in the inner lining of the colon or rectum.  It commonly develops from a tumor, an abnormal tissue which can be benign or malignant or from a polyp, a non-cancerous tumor.

The Philippine Council for Health Research and Development, one of the three sectoral councils of the Department of Science and Technology (PCHRD-DOST) and lead national agency responsible for coordination and monitoring health research initiatives in the country will mark its 30th year in service on 16 March 2012.

 
Professor Federico Macaranas of AIM facilitates the review of the Strategic Business Plan draft.

Task force members of the ASEAN Network for Drug, Diagnostics, and Vaccines Innovation (ASEAN-NDI) held a teleconference at the Asian Institute of Management (AIM) in Makati City last February 28, 2012 to review its draft Strategic Business Plan (SBP).

"The meeting was called to provide the task force members information on the progress of the SBP project. It also aims to gather reactions and post clarifications on the questionnaire provided prior to the meeting to make sure 

Dr. Antonio B. Bautista, Deputy Program Manager of the Field Operations Consolidated Global Fund Malaria Project tackles the development of malaria control in the country

“Malaria is one of the most persistent mosquito-borne infection in the Philippines. Prevalent areas are usually rural, mountainous and hard to reach.”

Dr. Antonio B. Bautista, Deputy Program Manager of the Field Operations Consolidated Global Fund Malaria Project from the Pilipinas Shell Foundation, Inc (PSFI), presented the status of malaria in the Philippines during the scientific conference of the 14th National Institutes of Health (NIH) anniversary last February.

The Philippines is one of the 20 countries in East Asia and the Pacific availing the Global Fund (GF) opportunity which is a unique global public/private partnership dedicated to attracting and disbursing additional resources to prevent and treat HIV/AIDS, tuberculosis and malaria.

In 2003, PSFI assisted in the formulation and development of the GF Round 2 project proposal for malaria. It was in 2005 when PSFI became the country’s principal recipient of the GF-Malaria grant covering the five most endemic provinces of the Philippines through the endorsement of the Country Coordinating Mechanism (CCM).

Dr. Bautista reported that before GF, 79 provinces were categorized endemic in the Philippines and only 13 were malaria-free provinces (1991-2002).

“Working with the GF, the project’s target was to cover 26 provinces by 2010. Strategies in reaching our target was through building local capacities, early diagnosis and prompt treatment, strengthening vector control, strengthening surveillance and epidemic management, ensuring quality of services, intensifying health promotion and establishing and expanding networks and collaborations,” said Dr. Bautista.

As early as 2008, the project reached the target of 76.8% reduction in morbidity rate of the 26 endemic provinces and a 90% reduction in mortality rate. The 13 Malaria-free provinces in 2002 became 23 Malaria-free provinces in 2008.

In 2009, the GF saw it fit to consolidate three projects on malaria: GF Round 2, Round 5 and Round 6. Their objectives were to ensure universal access to reliable diagnosis, highly effective and appropriate treatment and preventive measures, capacitate LGUs to own manage and sustain the Malaria Program in their respective localities, sustain financing of anti-malaria efforts at all levels of operations and ensure a functioning quality assurance system for Malaria operations.

From 2009-2010, the project have established 552 Rapid Diagnostic Test (RDT) sites and 987 Microscopy centers. In 2011, 95% of the diagnostic and treatment facilities were reported functional.

In strengthening and expanding vector control services in the country, the consolidated project have already distributed 2.7 million bed nets in a period of 2 years and 576,000 houses were sprayed with insecticides and 996,000 pregnancy packages were distributed among the 40 provinces in the Philippines (21 in Luzon and 19 in Mindanao).

Dr. Bautista reported that in 2011, the total LGU spending on Malaria amounted to 59 million and the DOH budget for Malaria was raised at 162 million.

“We are already doing everything. We just need to do it more correctly, regularly and in a timely manner,” concluded Dr. Bautista.